Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis

Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH 44195, USA.
American Journal of Kidney Diseases (Impact Factor: 5.76). 12/2008; 53(4):617-27. DOI: 10.1053/j.ajkd.2008.08.033
Source: PubMed

ABSTRACT Optimal hydration measures to prevent contrast-induced nephropathy are controversial.
We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings.
Adult patients undergoing contrast procedures.
Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy.
Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine.
Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure.
Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy.
Publication bias and heterogeneity.
Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

Download full-text


Available from: Sonal Singh, Aug 13, 2015
  • Source
    • "La perfusion IV de bicarbonate de sodium, proposée par Merten et al., a fait l'objet par la suite de nombreuses publications, certaines ayant trouvé une supériorité par rapport au soluté salé isotonique et d'autres non [38]. La méta-analyse la plus récente est cependant en faveur de l'utilisation de bicarbonate de sodium [39]. Le volume d'administration optimal n'est pas non plus clairement établi. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute kidney injury is a common complication after contrast administration in radiology or cardiology. It increases morbidity and in-hospital but also long-term mortality. The pathophysiology is complex, there is an association of direct cellular toxicity of contrast agents and medullary ischemia secondary to alterations in intra-renal hemodynamics and to an increase in metabolic activity. Many risk factors have been identified and should be checked prior to injection, the most important being pre-existing renal failure which might be identified by calculating the estimated glomerular filtration rate with predictive equations such as Cockcroft–Gault or MDRD equations. When risk factors are present and contrast administration is really necessary, the only validated measure to reduce the risk of renal failure is still volume expansion. Other pharmacological interventions have interesting results, but a confirmation on a larger scale is necessary. The volume expansion is best performed intravenously by the isotonic saline or sodium bicarbonate.
    La Presse Médicale 07/2010; 39(7):807-814. DOI:10.1016/j.lpm.2010.02.046 · 1.17 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute renal failure on the intensive care unit is associated with significant mortality and morbidity. To determine recommendations for the prevention of acute kidney injury (AKI), focusing on the role of potential preventative maneuvers including volume expansion, diuretics, use of inotropes, vasopressors/vasodilators, hormonal interventions, nutrition, and extracorporeal techniques. A systematic search of the literature was performed for studies using these potential protective agents in adult patients at risk for acute renal failure/kidney injury between 1966 and 2009. The following clinical conditions were considered: major surgery, critical illness, sepsis, shock, and use of potentially nephrotoxic drugs and radiocontrast media. Where possible the following endpoints were extracted: creatinine clearance, glomerular filtration rate, increase in serum creatinine, urine output, and markers of tubular injury. Clinical endpoints included the need for renal replacement therapy, length of stay, and mortality. Studies are graded according to the international Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) group system Several measures are recommended, though none carries grade 1A. We recommend prompt resuscitation of the circulation with special attention to providing adequate hydration whilst avoiding high-molecular-weight hydroxy-ethyl starch (HES) preparations, maintaining adequate blood pressure using vasopressors in vasodilatory shock. We suggest using vasopressors in vasodilatory hypotension, specific vasodilators under strict hemodynamic control, sodium bicarbonate for emergency procedures administering contrast media, and periprocedural hemofiltration in severe chronic renal insufficiency undergoing coronary intervention.
    Intensive Care Medicine 04/2010; 36(3):392-411. DOI:10.1007/s00134-009-1678-y · 5.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Das akute Nierenversagen (ANV) tritt, nach der aktuell entwickelten Definition, mit einer Inzidenz von bis zu 30% nach kardiochirurgischen Eingriffen auf, bei etwa 1% der Betroffenen als dialysepflichtiges Nierenversagen, weshalb der Begriff „cardiac surgery associated acute kidney injury“ (CSA AKI) geprägt wurde. Die ANV-assoziierte Mortalität liegt zwischen 15 und 30% und CSA AKI erhöht die Mortalität, unabhängig von der Komorbidität. Lediglich bei 50% der Überlebenden kommt es zur vollkommenen Regeneration der Nierenfunktion. Die Pathophysiologie des CSA AKI ist keineswegs auf den Einsatz der extrakorporalen Zirkulation begrenzt, sondern ausgesprochen komplex und multifaktoriell und beinhaltet v. a. endogene und exogene Nephrotoxine, Inflammation, Hypoperfusion sowie metabolische und neurohormonale Faktoren. Es existiert keine kausale Therapie des CSA AKI; extrakorporale Nierenersatzverfahren stellen lediglich eine supportive Therapie des ANV dar, um die Zeit bis zur renalen Regeneration zu überbrücken. Daher kommt der primären und sekundären Prävention des ANV mit Korrektur aller vermeidbaren und modifizierbaren Risikofaktoren die entscheidende Rolle zu.
    Zeitschrift für Herz- Thorax- und Gefäßchirurgie 06/2012; 26(3). DOI:10.1007/s00398-012-0927-5
Show more